Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venglustat PK in Renal Impairment
NCT03687554Phase 1Completed
- Sponsor
- Sanofi
- Start
- Oct 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of venglustat in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Sanofi. Primary endpoint: Area Under the Curve. Started Oct 2018; status: completed.
02
Drugs
venglustat
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT03687554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687554.